Company Name: Advinus Therapeutics Ltd.
Address: #21 & #22 Phase II, Peenya Industrial Area, Bangalore 560058, India
Tel. No: 91 80 2839 4959, 91-20-66539600, 91 9538961761
Email: info@advinus.com, bd@advinus.com, divya.c@advinus.com
Website: http://www.advinus.com/
Company Profile: Advinus Therapeutics is a research-based Pharmaceutical Company founded by leading global pharmaceutical executives and promoted by the TATA Group. The company is the first of its kind in India to offer end-to-end development services to the global Pharma, Agro and Biotech industries and at the same time creating long-term value through internal and collaborative innovative Drug Discovery.
Advinus has three operational sites. Advinus Drug Discovery, which is located in a state of the art facility in Pune (near Mumbai) is developing its own drug candidates with the objective of out-licensing them at preclinical or clinical stages. The therapeutic areas of focus of these programs are in Metabolic Diseases and Inflammatory Diseases.
Advinus is also working on the discovery of novel therapies for neglected diseases such as Leishmaniasis and Malaria. The aim of this program is to discover and develop new drugs for neglected diseases with speed, efficiency and cost effectiveness. India is ideally suited for this activity due to public health issues of the country, availability of talent and cost effectiveness. Advinus is committed to addressing these global public health issues.
· The Telerobotic-assisted Internal Mammary Artery Harvesting procedure was successfully completed in 58 minutes, with exceptional precision and…
This expansion enables DFE Pharma to offer specialized analytical services for Dry Powder Inhalation (DPI)…
Dr. Sujatha Thyagarajan, Lead & HOD - Pediatric Intensive Care and Pediatric Emergency at Aster…
Bangalore, January 13, 2025: Fortis Hospital Bannerghatta Road, has successfully treated a 53-year-old software engineer from…
Mumbai, January 13, 2025: In a landmark medical feat, a multidisciplinary team led by Dr.…
Mumbai, January 13, 2025: From the last six months, 21-year-old Pari Tulaskar [name changed) from…